Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Language
Publication year range
2.
FEMS Microbiol Lett ; 362(18): fnv142, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26347298

ABSTRACT

Screening of a bacterial artificial chromosome (BAC) library containing metagenomic DNA from human plaque and saliva allowed the isolation of four clones producing antimicrobial activity. Three of these were pigmented and encoded homologues of glutamyl-tRNA reductase (GluTR), an enzyme involved in the C5 pathway leading to tetrapyrole synthesis, and one clone had antibacterial activity with no pigmentation. The latter contained a BAC with an insert of 15.6 kb. Initial attempts to localize the gene(s) responsible for antimicrobial activity by subcloning into pUC-based vectors failed. A new plasmid for toxic gene expression (pTGEX) was designed enabling localization of the antibacterial activity to a 4.7-kb HindIII fragment. Transposon mutagenesis localized the gene to an open reading frame of 483 bp designated antibacterial protein1 (abp1). Abp1 was 94% identical to a hypothetical protein of Neisseria subflava (accession number WP_004519448.1). An Escherichia coli clone expressing Abp1 exhibited antibacterial activity against Bacillus subtilis BS78H, Staphylococcus epidermidis NCTC 11964 and B4268, and S. aureus NCTC 12493,ATCC 35696 and NCTC 11561. However, no antibacterial activity was observed against Pseudomonas aeruginosa ATCC 9027, N. subflava ATCC A1078, E. coli K12 JM109 and BL21(DE3) Fusobacterium nucleatum ATCC 25586 and NCTC 11326, Prevotella intermedia ATCC 25611, Veillonella parvula ATCC 10790 or Lactobacillus casei NCTC 6375.


Subject(s)
Anti-Bacterial Agents/chemistry , Bacterial Proteins/chemistry , Bacterial Proteins/pharmacology , Dental Plaque/microbiology , Metagenome , Neisseria/chemistry , Saliva/microbiology , Aldehyde Oxidoreductases/genetics , Amino Acid Sequence , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/pharmacology , Bacillus subtilis/drug effects , Bacteria/drug effects , Bacterial Proteins/isolation & purification , Chromosomes, Artificial, Bacterial , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli K12/drug effects , Genetic Vectors , Genomic Library , Humans , Lacticaseibacillus casei/drug effects , Molecular Sequence Data , Mutagenesis , Plasmids , Pseudomonas aeruginosa/drug effects , Sequence Analysis, DNA , Staphylococcus aureus/drug effects , Staphylococcus epidermidis/drug effects
3.
Appl Biochem Biotechnol ; 172(8): 3736-47, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24566926

ABSTRACT

Penicillin G acylase (PGA) is a commercially important enzyme that cleaves penicillin G to 6-amino penicillanic acid (6-APA) and phenyl acetic acid (PAA). The strain Bacillus badius has been identified as potential producer of PGA. A detailed calorimetric investigation on PGA production was carried out to enable generation of thermokinetic data possible for commercial application. Reaction calorimetric studies coupled with respirometric studies suggested that enzyme activity of the species B. badius was calorimetrically traceable. Three phases of growth were distinctly noticeable in the metabolic heat-time curve. Increase in enzymatic activity with restricted growth confirmed intracellular nature of the production process. The estimated heat yields due to biomass growth, 10.026 kJ/g, substrate consumption 22.761 kJ/g, and oxygen uptake 383 ± 10 kJ/mol helped to understand the energetic of the organism under study. Low oxycalorific coefficient confirmed the existence of fermentation-coupled metabolism of B. badius.


Subject(s)
Bacillus/metabolism , Bioreactors/microbiology , Penicillin Amidase/biosynthesis , Bacillus/growth & development , Biomass , Calorimetry , Culture Techniques , Fermentation , Hot Temperature , Oxidation-Reduction , Penicillin Amidase/metabolism , Time Factors
4.
Article in English | WPRIM (Western Pacific) | ID: wpr-233293

ABSTRACT

Metagenomics research has been developed over the past decade to elucidate the genomes of the uncultured microorganisms with an aim of understanding microbial ecology. On the other hand, it has also been provoked by the increasing biotechnological demands for novel enzymes, antibiotic and signal mimics. The gut microbiota of insects plays crucial roles in the growth, development and environmental adaptation to the host insects. Very recently, the insect microbiota and their genomes (microbiome), isolated from insects were recognized as a major genetic resources for bio-processing industry. Consequently, the exploitation of insect gut microbiome using metagenomic approaches will enable us to find novel biocatalysts and to develop innovative strategies for identifying smart molecules for biotechnological applications. In this review, we discuss the critical footstep in extraction and purification of metagenomic DNA from insect gut, construction of metagenomic libraries and screening procedure for novel gene identification. Recent innovations and potential applications in bioprocess industries are highlighted.

5.
Appl Biochem Biotechnol ; 171(6): 1328-38, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23949729

ABSTRACT

Bacillus badius isolated from soil has been identified as potential producer of penicillin G acylase (PGA). In the present study, batch experiments performed at optimized inoculum size, temperature, pH, and agitation yielded a maximum PGA of 9.5 U/ml in shake flask. The experiments conducted in bioreactor with different oxygen flow rates revealed that 0.66 vvm oxygen flow rate could be sufficient for the maximum PGA activity of 12.7 U/ml. From a detailed investigation on the strategies of the addition of phenyl acetic acid (PAA) for increasing the production of PGA, it was found that the controlled addition of 10 ml of 0.1 % (w/v) PAA once in every 2 h from 6th hour of growth showed the maximum PGA activity of 32 U/ml. Thus, our studies for the first time showed that at concentration above 0.1 % (w/v) PAA, the PGA production decreased. This selective condition paves the way for less costly bioprocess for the production of PGA.


Subject(s)
Bacillus/enzymology , Bacterial Proteins/biosynthesis , Batch Cell Culture Techniques/methods , Penicillin Amidase/biosynthesis , Phenylacetates/metabolism , Bacillus/growth & development , Bacillus/isolation & purification , Bacillus/metabolism , Bacterial Proteins/genetics , Bioreactors/microbiology , Culture Media/chemistry , Culture Media/metabolism , Penicillin Amidase/genetics , Phenylacetates/analysis , Soil Microbiology
6.
Int J Microbiol ; 2012: 317828, 2012.
Article in English | MEDLINE | ID: mdl-22518140

ABSTRACT

Controlled drug delivery technology represents one of the most rapidly advancing areas of science. They offer numerous advantages compared to conventional dosage forms including improved efficacy, reduced toxicity, improved patient compliance and convenience. Over the past several decades, many delivery tools or methods were developed such as viral vector, liposome-based delivery system, polymer-based delivery system, and intelligent delivery system. Recently, nonviral vectors, especially those based on biodegradable polymers, have been widely investigated as vectors. Unlike the other polymers tested, polyhydroxyalkanoates (PHAs) have been intensively investigated as a family of biodegradable and biocompatible materials for in vivo applications as implantable tissue engineering material as well as release vectors for various drugs. On the other hand, the direct use of these polyesters has been hampered by their hydrophobic character and some physical shortcomings, while its random copolymers fulfilled the expectation of biomedical researchers by exhibiting significant mechanical and thermal properties. This paper reviews the strategies adapted to make functional polymer to be utilized as delivery system.

SELECTION OF CITATIONS
SEARCH DETAIL
...